# Beta Blockade in Critical Injury

> **NCT00356187** · PHASE2 · TERMINATED · sponsor: **Denver Health and Hospital Authority** · enrollment: 15 (actual)

## Conditions studied

- Trauma

## Interventions

- **DRUG:** Propranolol

## Key facts

- **NCT ID:** NCT00356187
- **Lead sponsor:** Denver Health and Hospital Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-02-15
- **Primary completion:** 2009-01-31
- **Final completion:** 2009-01-31
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Slow enrollment, end of funding
- **Last updated:** 2018-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00356187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00356187, "Beta Blockade in Critical Injury". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00356187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*